Trial intelligence / Profile preview

Effect of Tocotrienols on Bone Health in Postmenopausal Women

NCT02058420Phase 2Completed

Sponsor
Texas Tech University Health Sciences Center
Start
Feb 2014
Primary completion
Oct 2022
Countries
1
01

Overview

Phase 2, randomised trial in osteoporosis (3 arms), sponsored by Texas Tech University Health Sciences Center. Primary endpoint: Serum Bone Resorption Marker at 12 weeks. Started Feb 2014; status: completed.

02

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT02058420.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02058420.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call